Klinefelter Syndrome

Klinefelter syndrome is a genetic condition in males caused by an extra X chromosome (47,XXY). It affects about 1 in 500 to 1,000 males, but many are never diagnosed. The testes are small and make less testosterone and few or no sperm. Features can include tall height, reduced body and facial hair, breast tissue growth (gynecomastia), low muscle mass, delayed or incomplete puberty, and infertility. Some boys have learning, language or attention difficulties. It raises the risk of osteoporosis, type 2 diabetes, autoimmune diseases and some other conditions. Testosterone treatment and fertility care can help.

Lab tests linked to Klinefelter syndrome:

• Estrogens, total (male): estrogen levels can be normal or raised relative to testosterone, which contributes to breast tissue growth.
• Klinefelter syndrome is confirmed with a karyotype, a chromosome test on a blood sample. Doctors also measure morning total testosterone, LH and FSH, and sometimes estradiol, SHBG and a semen analysis. They may check bone density, HbA1c and lipids.

How results are read:

• A low or low-normal testosterone with high LH and FSH (primary hypogonadism), in a man with small testes, suggests Klinefelter syndrome.
• A karyotype showing 47,XXY confirms it. Some people have mosaic forms, with a mix of cell types, and milder features.
• Estrogen results help explain gynecomastia but don't diagnose Klinefelter syndrome.
• Testosterone treatment is monitored with testosterone levels and a CBC.

When to see a doctor:

• See a doctor about delayed or incomplete puberty, small testes, breast growth in a boy or man, or infertility.
• Ask about fertility options before starting testosterone treatment, as testosterone can reduce sperm production further.

Clinical takeaway: Klinefelter syndrome is suspected from low testosterone with high LH and FSH, and confirmed with a karyotype.